Literature DB >> 1863819

Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients.

J C Torre Alonso1, A Rodriguez Perez, J M Arribas Castrillo, J Ballina Garcia, J L Riestra Noriega, C Lopez Larrea.   

Abstract

We carried out a prospective study of the clinical, laboratory and radiological features of 180 patients with psoriatic arthritis. We initially classified our patients into five groups as described in the publications of Moll and Wright. Thirty-seven per cent had oligoarthritis, 36% polyarthritis, 23% spondarthritis (sacroiliitis and/or spondylitis) and 4% had the mutilans form. The distal joint arthritis type did not exist as an entity and the distal interphalangeal (DIP) joints were affected in all groups. The spondarthritis form includes patients with exclusively axial manifestations and also those who in addition have peripheral arthritis (oligoarthritis, polyarthritis, DIP arthritis). Only 53% of our patients had nail involvement. We found an increase of IgA levels in patients with axial disease. This suggests a relationship between ankylosing spondylitis and psoriatic spondylitis. The HLA-B17/Cw6 association increased in the oligoarticular form. The increase of antigen B17 correlated with the spondarthritic and oligoarthritis forms whereas Cw6 was more important in the oligoarthritis form. An increase of the HLA-B27/Cw1 association and the spondarthritic form was also found. Moreover, we detected a greater incidence of the HLA-B27 antigen in patients with bilateral sacroiliitis (85%) than in patients with unilateral sacroiliitis (22%). Our work revealed that PA is not a harmless disease; 57% of our patients had erosive arthritis while 19% had ARA class III or IV functional impairment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863819     DOI: 10.1093/rheumatology/30.4.245

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  66 in total

Review 1.  Psoriatic arthritis and imaging.

Authors:  P A Ory; D D Gladman; P J Mease
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

2.  Classification and categorisation of psoriatic arthritis.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2008-07-16       Impact factor: 2.980

3.  Can we identify psoriatic arthritis early?

Authors:  Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

4.  Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate.

Authors:  J Gratacós; E Casado; J Real; J C Torre-Alonso
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

Review 5.  Imaging of the sacroiliac joint involvement in seronegative spondylarthropathies.

Authors:  Giuseppe Guglielmi; Giacomo Scalzo; Alessia Cascavilla; Marina Carotti; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2009-06-13       Impact factor: 2.980

Review 6.  Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature.

Authors:  Soumya M Reddy; Sheila Crean; Amber L Martin; Meghan D Burns; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

Review 7.  Psoriatic arthritis: phenotypic variance and nosology.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

8.  Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis.

Authors:  Rubens Bonfiglioli; Roseneide A Conde; Percival D Sampaio-Barros; Paulo Louzada-Junior; Eduardo A Donadi; Manoel B Bertolo
Journal:  Clin Rheumatol       Date:  2007-11-03       Impact factor: 2.980

Review 9.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

10.  Psoriatic arthritis: pharmacoeconomic considerations.

Authors:  Ignazio Olivieri; Lorenzo Giovanni Mantovani; Salvatore D'Angelo; Angela Padula; Simona de Portu
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.